Kavis-D Tablets
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
MFDS item code 201605014 · Approved 2016.08.19
This product's status changed to Approval withdrawn on 2023.09.27. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastrointestinal disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.); prevention of Mendelson's syndrome
This medication is used for gastrointestinal diseases such as gastric and duodenal ulcers, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also administered to prevent Mendelson’s syndrome prior to anesthesia and is effective in treating ulcers after surgery and gastric/duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It helps improve various gastrointestinal diseases and symptoms.
1. Adults Usually, regardless of meals, administer 1 tablet per dose orally twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 1 tablet per dose twice daily or 2 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets per dose twice daily, in the morning and at bedtime. The dosage is the same for ulcers caused by nonsteroidal anti-inflammatory drugs or for combination therapy to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drug use are usually healed within 4 weeks, and ulcers are usually healed within 8 weeks; however, healing may occasionally take longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 1 tablet per dose twice daily for 8 weeks or 2 tablets per dose once daily at bedtime. However, the dose may be increased to 2 tablets per dose 4 times a day in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Start treatment with an initial dose of 1 tablet per dose 3 times a day, and increase the dose if necessary. In severe cases, up to 6 g per day of ranitidine may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet per dose twice daily. 5) Premedication for anesthesia (prevention of Mendelson syndrome) Administer 1 tablet per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 1 tablet per dose on the night before surgery.
This medication should not be used in patients undergoing dialysis or those with kidney dysfunction. Additionally, it should not be administered to patients who have had allergic reactions to this medication or its components, a history of acute porphyria, those who have undergone upper gastrointestinal surgery, pregnant women or those who may become pregnant, premature infants, newborns, and patients following diets that restrict potassium intake. Patients with impaired liver function or a history of drug allergies, elderly patients, patients with a history of kidney disease, and patients taking NSAIDs should use this medication cautiously. Particularly, since it may mask symptoms of stomach cancer, patients with gastric ulcers or middle-aged individuals presenting new dyspeptic symptoms should be checked for malignant conditions before treatment. Patients with Helicobacter pylori infection with gastric or duodenal ulcers require eradication therapy, and caution is needed for critically ill patients in intensive care units or those with hypophosphatemia or swallowing difficulties. Rarely, serious allergic reactions such as anaphylactic shock may occur during treatment with this medication, so if any unusual symptoms appear, it should be discontinued immediately, and appropriate treatment sought. Skin rash, hives, angioedema, fever, and dyspnea are also rare hypersensitivity reactions, so caution is required. Abnormal blood test results may appear, and if signs of liver dysfunction, arrhythmia, gastrointestinal symptoms, dizziness, drowsiness, or neurological symptoms like confusion appear, immediate consultation with healthcare professionals is advised. This medication should not be taken for prolonged periods, and if there is no therapeutic effect, it may be switched to another medication. If dizziness or drowsiness occurs while taking this medication, it is advised to avoid driving or operating hazardous machinery. There may be interactions with other medications, especially anticoagulants or certain antibiotics and anticonvulsants, so patients should inform their physician or pharmacist. It is safest for pregnant or breastfeeding women not to use this medication, and its safety in children is not established, thus it is advised not to administer it. In case of overdose, emergency procedures such as inducing vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be required. This medication reduces gastric acid secretion, which may promote bacterial growth in the stomach; therefore, additional monitoring such as ophthalmic examinations is needed for long-term use.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to safely preserve the medication's effectiveness.
Green biconvex film-coated tablet
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Ranitidine Hydrochloride 168mg · Tripotassium Bismuth Dicitrate 200mg +1 more
Tablet · Prescription medication · Combination
Kyungbo Pharmaceutical Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Nexpharm Korea Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
HUONS BioScience Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationRanitidine Hydrochloride 84mg · Tripotassium Bismuth Dicitrate 100mg +1 more
Tablet · Prescription medication · Combination
Teragen Etex Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Korea Pavise Pharmaceutical Co., Ltd.
Ranitidine Hydrochloride 84mg · Sucralfate Hydrate 300mg +1 more
Tablet · Prescription medication · Combination
Kwangdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.